Literature DB >> 21326919

The many roads traveled by Helicobacter pylori to NFκB activation.

Acacia Lamb1, Lin-Feng Chen.   

Abstract

Many of the pathologies linked to Helicobacter pylori are caused by the ability of the bacteria to induce chronic inflammation in the stomach of the host. One of the major transcription factors that regulate inflammation is NFκB, which is constitutively activated in many cancers including some gastric cancers. H. pylori has been shown to activate NFκB using several different bacterial components and host signaling pathways in cell-type and strain-specific ways. Our recent studies demonstrate that H. pylori utilizes its virulence factor CagA to target signaling molecule TAK1 for the activation of NFκB. In this article, we will summarize our findings together with other recent progress in the H. pylori-mediated activation of NFκB and discuss the role of CagA and TAK1 in the H. pylori-mediated activation of NFκB and gastric diseases.

Entities:  

Year:  2010        PMID: 21326919      PMCID: PMC3023589          DOI: 10.4161/gmic.1.2.11587

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  43 in total

1.  Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines.

Authors:  Sebastian Rubinsztein-Dunlop; Bruno Guy; Ling Lissolo; Hans Fischer
Journal:  J Med Microbiol       Date:  2005-05       Impact factor: 2.472

2.  NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein.

Authors:  Sabine Brandt; Terry Kwok; Roland Hartig; Wolfgang König; Steffen Backert
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-21       Impact factor: 11.205

Review 3.  The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease.

Authors:  A Ibraghimov; J Pappo
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

4.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

5.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

6.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

Review 7.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

8.  The PAK1 autoregulatory domain is required for interaction with NIK in Helicobacter pylori-induced NF-kappaB activation.

Authors:  Manfred Neumann; Anna Foryst-Ludwig; Stefanie Klar; Katrin Schweitzer; Michael Naumann
Journal:  Biol Chem       Date:  2006-01       Impact factor: 3.915

9.  MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells.

Authors:  Yoshihiro Hirata; Tomoya Ohmae; Wataru Shibata; Shin Maeda; Keiji Ogura; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

10.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

View more
  20 in total

Review 1.  New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection.

Authors:  Ying-Hung Nicole Tsang; Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

Review 2.  Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer.

Authors:  Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-03       Impact factor: 4.429

Review 3.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

4.  Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

Authors:  Ana Magalhães; Ricardo Marcos-Pinto; Alison V Nairn; Mitche Dela Rosa; Rui M Ferreira; Susana Junqueira-Neto; Daniela Freitas; Joana Gomes; Patrícia Oliveira; Marta R Santos; Nuno T Marcos; Wen Xiaogang; Céu Figueiredo; Carla Oliveira; Mário Dinis-Ribeiro; Fátima Carneiro; Kelley W Moremen; Leonor David; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-07-02

5.  BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation.

Authors:  Jinjing Chen; Zhen Wang; Xiangming Hu; Ruichuan Chen; Judith Romero-Gallo; Richard M Peek; Lin-Feng Chen
Journal:  J Immunol       Date:  2016-04-15       Impact factor: 5.422

6.  Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32.

Authors:  Shoumin Zhu; Mohammed Soutto; Zheng Chen; DunFa Peng; Judith Romero-Gallo; Uma S Krishna; Abbes Belkhiri; M Kay Washington; Richard Peek; Wael El-Rifai
Journal:  Gut       Date:  2016-09-02       Impact factor: 23.059

Review 7.  Helicobacter pylori and interleukin-8 in gastric cancer.

Authors:  Ko Eun Lee; Pham Ngoc Khoi; Yong Xia; Jung Sun Park; Young Eun Joo; Kyung Keun Kim; Seok Yong Choi; Young Do Jung
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

8.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

9.  Helicobacter pylori activates NF-κB by inducing Ubc13-mediated ubiquitination of lysine 158 of TAK1.

Authors:  Acacia Lamb; JinJing Chen; Steven R Blanke; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-10       Impact factor: 4.429

10.  Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells.

Authors:  Jessica Baud; Christine Varon; Sandrine Chabas; Lucie Chambonnier; Fabien Darfeuille; Cathy Staedel
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.